CN Patent

CN104666239A — 酒石酸溴莫尼定凝胶及其制备方法

Assigned to Hainan Puli Pharmacy Stock Co Ltd · Expires 2015-06-03 · 11y expired

What this patent protects

本发明涉及医药制剂，尤其涉及酒石酸溴莫尼定凝胶及其制备方法。由包括如下组分的物料制备得到：酒石酸溴莫尼定0.2%~2%、抗氧化剂0.01~1%、保湿剂2%~20%、金属螯合离子0.01%~1%、增溶剂2%~20%、防腐剂0.01%~1%、促渗剂0.05%~5%、增稠剂0.1%~2%、水相溶剂20%~50%、油相容剂20%~50%，PH值调节到5.0~6.0。本发明提供的酒石酸溴莫尼定凝胶剂，作用于局部患处，具备使用方便、起效快且副作用小等优点。

USPTO Abstract

本发明涉及医药制剂，尤其涉及酒石酸溴莫尼定凝胶及其制备方法。由包括如下组分的物料制备得到：酒石酸溴莫尼定0.2%~2%、抗氧化剂0.01~1%、保湿剂2%~20%、金属螯合离子0.01%~1%、增溶剂2%~20%、防腐剂0.01%~1%、促渗剂0.05%~5%、增稠剂0.1%~2%、水相溶剂20%~50%、油相容剂20%~50%，PH值调节到5.0~6.0。本发明提供的酒石酸溴莫尼定凝胶剂，作用于局部患处，具备使用方便、起效快且副作用小等优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN104666239A
Jurisdiction
CN
Classification
—
Expires
2015-06-03
Drug substance claim
No
Drug product claim
No
Assignee
Hainan Puli Pharmacy Stock Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.